ARCHIVES

Kadcyla Extends Median PFS In Open-Label Phase III Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

RFP: Intellectual Property.

March 31, 2000

NIH Responds To IOM Report On Women’s Health Initiative

November 12, 1993

Acupuncture Eases Radiation-Induced Dry Mouth In Patients

April 24, 2009

NCI to Implement More Transparent Formula For Calculating Cancer Center Support Grants

June 11, 2014

Deluge Of SBIR Contract Proposals Changes Picture at NCI, Could Save $5 Million For Cancer

April 12, 1985

Comprehensive Centers Should Emphasize New Treatment, Group Says

July 27, 1979